Jacobson Pharma to go public in Hong Kong
Jacobson Pharma Corp, maker of the Po Chai pills used to treat indigestion and prevent hangovers, is seeking a $200m IPO in Hong Kong via sole sponsor BoC International.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: